Startups · AI

Head of Platform Bioengineering & Assay Development

Parallel Bio · San Francisco, CA · On-site

← All jobs
About Parallel Bio

Using the immune system to cure disease. Backed by Y Combinator.

About the role

As Principal Scientist, you will lead the science at our San Francisco site. You will manage our team of scientists and research associates, set experimental strategy, and own the scientific decisions that determine where we invest our experimental effort. You will remain personally at the bench on the hardest problems.

What they're looking for

  • A deeply experienced experimental scientist. You have spent your career developing complex biological assays and understand how difficult it is to make living systems behave reproducibly
  • A rigorous troubleshooter. When data are ambiguous, you design experiments that distinguish competing explanations rather than relying on intuition alone
  • A systems thinker. You understand that biological performance emerges from the interaction of cells, reagents, protocols, operators, instruments, automation, software, and data systems
  • Hands-on. You are comfortable setting scientific strategy and equally comfortable going to the bench when a difficult problem requires it
  • Comfortable with ambiguity. You can bring structure to immature technologies without imposing unnecessary bureaucracy or pretending uncertainty does not exist
  • Mission driven. You are excited by the opportunity to replace animal models with scalable human biology and fundamentally change how medicines are discovered
More about this role

Drug discovery has a translation problem: more than 95% of drugs that succeed in animal models fail in humans. We're building the alternative: human-first drug discovery, powered by organoids and AI, running on real human biology from the very first experiment.

Our platform is 87% concordant with clinical patient data - a vast improvement over the 3% translational success rate of animals. We’ve demonstrated the ability to model immunotoxicology, immunogen stimulation, and two autoimmune diseases with more on the way. Numerous pharma partners including 3 Fortune 500 companies are already using the platform. We've raised ~$30M from AIX Ventures, Marc Benioff, Jeff Dean, and Y Combinator. With the FDA Modernization Act 3.0 and the FDA's March 2026 validation framework, the regulatory tailwinds only continue to get stronger.

The opportunity ahead of the company is generational: build the first scaled engine for generating real human biological data, and use it to fundamentally change how medicines are discovered.

As Principal Scientist, you will lead the science at our San Francisco site.

You will manage our team of scientists and research associates, set experimental strategy, and...

Read the full posting on Parallel Bio's site ↗

Engineering

Build your edge while you search

Free tools for founders and investors, plus VC Unfiltered, our take on startups, venture and the people who build them.